Grants and Contracts Details
Description
We hypothesize that interleukin 1 receptor antagonist (IL-1Ra) administered intra-articularly during the early phases of acute ACL injury will provide symptomatic pain relief and decrease synovial fluid inflammatory markers and cartilage degradation.
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/12 → 2/28/15 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.